the day is not over and 33 US§ should be possible - specially after Rachel McMinn comment:
Cowen & Co. analyst Rachel McMinn views Monday's selloff as an overreaction to expected news. She reiterated her outperform raring on Vertex.
"We believe that yesterday's [Vertex] sell off was driven by an over-reaction to two-week old information. Timelines for commercial launch of ... telaprevir (late 2010/early 2010) are unchanged, and we see 50% upside relative to the market on the basis of this timeframe. While probability of an early 2009 FDA approval is low, we see 100% upside relative to the market under this scenario over the next 6-12 months."
it amazes me how some of these hedge funds listen to these analysts rather than doing their own research. It kind of worries me because i am sure my retirement fund is giving some of the funds to these idiots to invest. Good luck.